Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China
· Delayed Price · Currency is CNY 25.69
+0.22 (0.86%)
Last updated: May 12, 2025
SHE:300937 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Operating Revenue | 4,248 | 4,348 | 4,407 | 3,946 | 3,384 | 2,774 | Upgrade
|
Other Revenue | 32.87 | 32.87 | 23.54 | 23.65 | 16.23 | 15.84 | Upgrade
|
| Revenue | 4,281 | 4,381 | 4,430 | 3,969 | 3,401 | 2,790 | Upgrade
|
Revenue Growth (YoY) | -5.83% | -1.12% | 11.62% | 16.72% | 21.88% | 21.87% | Upgrade
|
Cost of Revenue | 3,876 | 4,001 | 4,073 | 3,663 | 3,219 | 2,596 | Upgrade
|
Gross Profit | 404.7 | 379.82 | 357.85 | 306.05 | 181.48 | 194.4 | Upgrade
|
Selling, General & Admin | 352.79 | 321.89 | 247.44 | 218.86 | 164.5 | 125.01 | Upgrade
|
Research & Development | 13.44 | 15.47 | 19.32 | 17.71 | 11.38 | - | Upgrade
|
Other Operating Expenses | 8.01 | 7.21 | 7.4 | 6.47 | 5.11 | 5.26 | Upgrade
|
Operating Expenses | 373.64 | 350.66 | 283.89 | 247.86 | 181.44 | 131.88 | Upgrade
|
Operating Income | 31.06 | 29.16 | 73.97 | 58.19 | 0.04 | 62.51 | Upgrade
|
Interest Expense | -9.68 | -9.71 | -6.58 | -6.42 | -1.82 | -1.82 | Upgrade
|
Interest & Investment Income | 3.88 | 3.87 | 3.81 | 2.38 | 9.65 | 2.1 | Upgrade
|
Currency Exchange Gain (Loss) | 0 | 0 | -0 | -0 | - | - | Upgrade
|
Other Non Operating Income (Expenses) | -4.78 | -4.66 | -6.17 | -10.31 | -3.94 | -3.59 | Upgrade
|
EBT Excluding Unusual Items | 20.49 | 18.66 | 65.02 | 43.83 | 3.93 | 59.2 | Upgrade
|
Impairment of Goodwill | - | - | - | -1.62 | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | -1.81 | -1.84 | - | -4.29 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.58 | -0.61 | -0.05 | -0.08 | -0.11 | -0.06 | Upgrade
|
Asset Writedown | -2 | 0.4 | -0.01 | -0.11 | -0 | -0.03 | Upgrade
|
Other Unusual Items | 0.57 | 0.56 | 4.92 | 7.16 | 4.3 | 2.72 | Upgrade
|
Pretax Income | 16.66 | 17.18 | 69.88 | 44.89 | 8.12 | 61.83 | Upgrade
|
Income Tax Expense | 4.21 | 1.78 | 13.11 | 8.75 | 1.4 | 9.41 | Upgrade
|
Earnings From Continuing Operations | 12.45 | 15.4 | 56.77 | 36.14 | 6.73 | 52.42 | Upgrade
|
Minority Interest in Earnings | -1.13 | 0.96 | 2.76 | 5.88 | -0.33 | 1.6 | Upgrade
|
Net Income | 11.32 | 16.36 | 59.53 | 42.02 | 6.4 | 54.02 | Upgrade
|
Net Income to Common | 11.32 | 16.36 | 59.53 | 42.02 | 6.4 | 54.02 | Upgrade
|
Net Income Growth | -69.52% | -72.52% | 41.69% | 556.48% | -88.15% | -16.46% | Upgrade
|
Shares Outstanding (Basic) | 96 | 96 | 96 | 95 | 91 | 72 | Upgrade
|
Shares Outstanding (Diluted) | 96 | 96 | 96 | 95 | 91 | 72 | Upgrade
|
Shares Change (YoY) | 0.27% | 0.21% | 0.56% | 4.44% | 26.94% | 0.24% | Upgrade
|
EPS (Basic) | 0.12 | 0.17 | 0.62 | 0.44 | 0.07 | 0.75 | Upgrade
|
EPS (Diluted) | 0.12 | 0.17 | 0.62 | 0.44 | 0.07 | 0.75 | Upgrade
|
EPS Growth | -69.60% | -72.58% | 40.91% | 528.57% | -90.67% | -16.67% | Upgrade
|
Free Cash Flow | 199.76 | 95.48 | -150.8 | 134.35 | -185.81 | 34.1 | Upgrade
|
Free Cash Flow Per Share | 2.08 | 0.99 | -1.57 | 1.41 | -2.03 | 0.47 | Upgrade
|
Dividend Per Share | 0.100 | 0.100 | 0.220 | 0.200 | - | 0.200 | Upgrade
|
Dividend Growth | -54.55% | -54.55% | 10.00% | - | - | - | Upgrade
|
Gross Margin | 9.45% | 8.67% | 8.08% | 7.71% | 5.34% | 6.97% | Upgrade
|
Operating Margin | 0.73% | 0.67% | 1.67% | 1.47% | 0.00% | 2.24% | Upgrade
|
Profit Margin | 0.26% | 0.37% | 1.34% | 1.06% | 0.19% | 1.94% | Upgrade
|
Free Cash Flow Margin | 4.67% | 2.18% | -3.40% | 3.38% | -5.46% | 1.22% | Upgrade
|
EBITDA | 50.31 | 48.37 | 93.03 | 77.46 | 13.37 | 72.55 | Upgrade
|
EBITDA Margin | 1.18% | 1.10% | 2.10% | 1.95% | 0.39% | 2.60% | Upgrade
|
D&A For EBITDA | 19.25 | 19.21 | 19.06 | 19.27 | 13.33 | 10.04 | Upgrade
|
EBIT | 31.06 | 29.16 | 73.97 | 58.19 | 0.04 | 62.51 | Upgrade
|
EBIT Margin | 0.73% | 0.67% | 1.67% | 1.47% | 0.00% | 2.24% | Upgrade
|
Effective Tax Rate | 25.27% | 10.34% | 18.76% | 19.50% | 17.17% | 15.22% | Upgrade
|
Revenue as Reported | - | - | - | 3,969 | 3,401 | 2,790 | Upgrade
|
Advertising Expenses | - | 76.51 | 36.27 | 28.48 | 19.98 | 9.61 | Upgrade
|
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.